BAL has been described as an uncommon subtype of B-ALL; it presents with a unique immunotype characterised by the expression of pan-B-cell markers (such as CD10, CD19, CD20, cCD79a). Here, CD19 is linked to precursor B-cell acute lymphoblastic leukemia.